On September 5, 2019 VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported that Jeff Baxter, President and CEO, will present at the H.C. Wainwright 21st Annual Global Investment Conference in New York City on Tuesday, September 10, 2019, at 8:20 AM ET (Press release, VBI Vaccines, SEP 5, 2019, View Source [SID1234539310]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

- Event: H.C. Wainwright 21st Annual Global Investment Conference
- Date: Tuesday, September 10, 2019
- Time: 8:20 – 8:45 AM ET
- Webcast: View Source

A live webcast of the presentation may also be accessed by visiting the Investors page of VBI’s website at www.vbivaccines.com.

On September 5, 2019 CollPlant (NASDAQ: CLGN), a regenerative medicine company, reported that Yehiel Tal, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on Tuesday, September 10th, 2019 at 1:45 pm EDT (Press release, CollPlant, SEP 5, 2019, View Source;renshaw-global-investment-conference-300912408.html [SID1234539327]). Mr. Tal will provide an overview of the Company’s business, including in the fields of medical aesthetics, breast implants and 3D bioprinting of life saving organs. Institutional investors and analysts that are attending the conference may request a one-on-one meeting through the conference coordinators.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: 21st Annual Rodman & Renshaw Global Investment Conference
Date: September 10, 2019
Time: 1:45 -2:10 pm (Eastern Time)
Location: Holmes II Room, St Lotte New York Palace Hotel in New York City

On September 5, 2019 Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, reported that Kirk Look, Chief Financial Officer of Oncolytics Biotech, will present at the H.C. Wainwright 21st Annual Global Investment Conference at 5:30 pm Eastern Time on Monday, September 9, 2019 (Press release, Oncolytics Biotech, SEP 5, 2019, View Source [SID1234539311]). The conference is being held September 8-10, 2019 at the Lotte New York Palace Hotel.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio link to the webcast session will be available on the Company’s website at View Source It is recommended that listeners log on 10 minutes in advance of the live session to register and download any necessary software. An audio replay will be accessible approximately two hours following the presentation on the Oncolytics website.

On September 5, 2019 ESSA Pharma Inc. (TSX-V: EPI;Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer reported the Company will be presenting at the H.C. Wainwright 21st Annual Global Investment Conference on Monday September 9, 2019 at 5:05pm EDT at the Lotte New York Palace Hotel in New York (Press release, ESSA, SEP 5, 2019, https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-hc-wainwright-21st-annual-global-investment-conference-300912093.html [SID1234539328]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. David. R. Parkinson, Chief Executive Officer, will provide a corporate overview of the Company’s business and will be available for one-on-one meetings from September 9 – 10, 2019. ESSA’s Chief Financial Officer, David S. Wood, and Chief Operating Officer, Peter Virsik, will also be in attendance.

The presentation will be webcast live and can be accessed through the Investor Relations page at www.essapharma.com. A replay of the presentation will be available on the Company’s website for 90 days.

Presentation Details :

Presentation Date:

Monday September 9, 2019

Presentation Time:

5:05pm Eastern Standard Time

Location:

Lotte New York Palace Hotel

On September 5, 2019 KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that its president and chief executive officer, Travis C. Mickle, Ph.D., will present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co. being held September 8-10, 2019, at the Lotte New York Palace Hotel (Press release, KemPharm, SEP 5, 2019, http://investors.kempharm.com/news-releases/news-release-details/kempharm-present-21st-annual-global-investment-conference [SID1234539312]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of KemPharm’s presentation are as follows:

Event: 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.
Date: Monday, September 9, 2019
Time: 2:35 PM ET
Location: Lotte New York Palace Hotel, New York, NY
The presentation will be webcast and available on the Investor Relations section of the Company’s website at View Source